CCDC158
geneOn this page
Also known as FLJ25770
Summary
CCDC158 (coiled-coil domain containing 158, HGNC:26374) is a protein-coding gene on chromosome 4q21.1, encoding Coiled-coil domain-containing protein 158 (Q5M9N0). Plays a role in receptor-mediated endocytosis in proximal tubular cells of the kidney.
At a glance
- Gene–disease (curated): renal tubule disorder (Limited, GenCC)
- GWAS associations: 4
- Clinical variants (ClinVar): 190 total
- MANE Select transcript:
NM_001394954
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26374 |
| Approved symbol | CCDC158 |
| Name | coiled-coil domain containing 158 |
| Location | 4q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25770 |
| Ensembl gene | ENSG00000163749 |
| Ensembl biotype | protein_coding |
| OMIM | 621144 |
| Entrez | 339965 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000388914, ENST00000434846, ENST00000504667, ENST00000504868, ENST00000509851, ENST00000682701
RefSeq mRNA: 2 — MANE Select: NM_001394954
NM_001042784, NM_001394954
CCDS: CCDS43242, CCDS93551
Canonical transcript exons
ENST00000682701 — 25 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001077897 | 76383662 | 76383738 |
| ENSE00001077899 | 76384088 | 76384415 |
| ENSE00001077901 | 76379290 | 76379404 |
| ENSE00001077902 | 76353123 | 76353281 |
| ENSE00001077903 | 76382610 | 76382720 |
| ENSE00001077908 | 76351720 | 76351812 |
| ENSE00001504385 | 76367294 | 76367776 |
| ENSE00001504387 | 76369426 | 76369623 |
| ENSE00001504388 | 76371417 | 76371536 |
| ENSE00002085916 | 76412090 | 76412132 |
| ENSE00003478135 | 76355324 | 76355436 |
| ENSE00003483217 | 76396269 | 76396486 |
| ENSE00003534731 | 76325857 | 76326015 |
| ENSE00003570998 | 76328900 | 76328967 |
| ENSE00003579651 | 76362126 | 76362315 |
| ENSE00003594220 | 76384556 | 76384665 |
| ENSE00003603730 | 76323302 | 76323409 |
| ENSE00003624684 | 76331344 | 76331403 |
| ENSE00003625744 | 76350996 | 76351121 |
| ENSE00003627138 | 76332432 | 76332491 |
| ENSE00003671469 | 76357374 | 76357526 |
| ENSE00003916117 | 76334010 | 76334167 |
| ENSE00003917074 | 76313039 | 76313246 |
| ENSE00003919006 | 76420965 | 76421141 |
| ENSE00003920445 | 76403138 | 76403280 |
Expression profiles
Bgee: expression breadth ubiquitous, 151 present calls, max score 98.12.
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.12 | gold quality |
| left testis | UBERON:0004533 | 89.74 | gold quality |
| right testis | UBERON:0004534 | 89.26 | gold quality |
| testis | UBERON:0000473 | 87.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.34 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.63 | gold quality |
| islet of Langerhans | UBERON:0000006 | 73.68 | gold quality |
| right coronary artery | UBERON:0001625 | 72.53 | gold quality |
| buccal mucosa cell | CL:0002336 | 70.95 | silver quality |
| cortical plate | UBERON:0005343 | 69.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 68.04 | gold quality |
| left coronary artery | UBERON:0001626 | 67.94 | gold quality |
| coronary artery | UBERON:0001621 | 66.80 | gold quality |
| sural nerve | UBERON:0015488 | 66.69 | gold quality |
| tibial artery | UBERON:0007610 | 66.63 | gold quality |
| popliteal artery | UBERON:0002250 | 66.61 | gold quality |
| aorta | UBERON:0000947 | 66.27 | gold quality |
| ascending aorta | UBERON:0001496 | 66.23 | gold quality |
| thoracic aorta | UBERON:0001515 | 66.16 | gold quality |
| calcaneal tendon | UBERON:0003701 | 66.10 | gold quality |
| adult organism | UBERON:0007023 | 65.54 | gold quality |
| right lobe of liver | UBERON:0001114 | 64.89 | gold quality |
| mucosa of stomach | UBERON:0001199 | 64.71 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 64.10 | gold quality |
| pancreas | UBERON:0001264 | 63.66 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 63.41 | gold quality |
| thyroid gland | UBERON:0002046 | 63.20 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 62.39 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 61.56 | gold quality |
| prefrontal cortex | UBERON:0000451 | 61.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.33 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting CCDC158, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-548AV-5P | 99.60 | 70.84 | 2107 |
| HSA-MIR-548K | 99.60 | 70.84 | 2107 |
| HSA-MIR-8054 | 99.48 | 70.81 | 2084 |
| HSA-MIR-122B-3P | 99.21 | 68.90 | 1333 |
| HSA-MIR-21-3P | 99.21 | 68.95 | 1312 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-6780A-3P | 98.42 | 67.49 | 1518 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc158 | ENSMUSG00000050050 |
| rattus_norvegicus | Ccdc158 | ENSRNOG00000002204 |
Paralogs (44): MYH13 (ENSG00000006788), MYO16 (ENSG00000041515), MYO9A (ENSG00000066933), MYO3B (ENSG00000071909), MYH7B (ENSG00000078814), MYO15A (ENSG00000091536), MYH7 (ENSG00000092054), MYO3A (ENSG00000095777), MYO9B (ENSG00000099331), MYH9 (ENSG00000100345), MYH14 (ENSG00000105357), MYH1 (ENSG00000109061), MYH3 (ENSG00000109063), MYH2 (ENSG00000125414), MYO1B (ENSG00000128641), MYO5C (ENSG00000128833), CGNL1 (ENSG00000128849), MYH8 (ENSG00000133020), MYH10 (ENSG00000133026), MYH11 (ENSG00000133392), MYO18B (ENSG00000133454), CCDC102A (ENSG00000135736), MYO1G (ENSG00000136286), MYO7A (ENSG00000137474), MYO1F (ENSG00000142347), CGN (ENSG00000143375), TMF1 (ENSG00000144747), MYH15 (ENSG00000144821), MYO10 (ENSG00000145555), CCDC102B (ENSG00000150636), MYO1E (ENSG00000157483), MYO1A (ENSG00000166866), MYO5B (ENSG00000167306), MYO7B (ENSG00000169994), MYO1H (ENSG00000174527), MYO1D (ENSG00000176658), MYO18A (ENSG00000196535), MYO6 (ENSG00000196586), MYO5A (ENSG00000197535), MYH6 (ENSG00000197616)
Protein
Protein identifiers
Coiled-coil domain-containing protein 158 — Q5M9N0 (reviewed: Q5M9N0)
All UniProt accessions (2): A0A804HIY6, Q5M9N0
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in receptor-mediated endocytosis in proximal tubular cells of the kidney.
Subunit / interactions. Interacts with clathrin and RAB5.
Subcellular location. Cytoplasmic vesicle. Clathrin-coated vesicle. Early endosome.
Tissue specificity. Expressed in testis and kidney. Expressed in testis. Expressed in testis and kidney.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5M9N0-1 | 1 | yes |
| Q5M9N0-2 | 2 | |
| Q5M9N0-3 | 3 |
RefSeq proteins (2): NP_001036249, NP_001381883* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031809 | CCDC158 | Family |
Pfam: PF15921
UniProt features (20 total): compositionally biased region 7, region of interest 3, splice variant 3, sequence variant 3, coiled-coil region 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5M9N0-F1 | 73.43 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 31 (showing top):
GOBP_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, GOBP_IMPORT_INTO_CELL, GOBP_ENDOCYTOSIS, GOCC_CLATHRIN_COATED_VESICLE, chr4q21, GOMF_CLATHRIN_BINDING, GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, HMGA1_TARGET_GENES, MAFG_TARGET_GENES, MIR12136, MIR23A_3P_MIR23B_3P, MIR23C, MIR4477A
GO Biological Process (1): receptor-mediated endocytosis (GO:0006898)
GO Molecular Function (2): clathrin binding (GO:0030276), protein binding (GO:0005515)
GO Cellular Component (2): early endosome (GO:0005769), clathrin-coated vesicle (GO:0030136)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| endocytosis | 1 |
| protein binding | 1 |
| binding | 1 |
| endosome | 1 |
| coated vesicle | 1 |
Protein interactions and networks
STRING
490 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC158 | TMEM236 | Q5W0B7 | 531 |
| CCDC158 | TXLNB | Q8N3L3 | 516 |
| CCDC158 | NUP54 | Q7Z3B4 | 505 |
| CCDC158 | NCLN | Q969V3 | 490 |
| CCDC158 | HELQ | Q8TDG4 | 466 |
| CCDC158 | PAFAH2 | Q99487 | 459 |
| CCDC158 | DNAAF8 | Q8IYS4 | 448 |
| CCDC158 | PPEF2 | O14830 | 447 |
| CCDC158 | SDAD1 | Q9NVU7 | 420 |
| CCDC158 | ZNF615 | Q8N8J6 | 419 |
| CCDC158 | MASTL | Q96GX5 | 418 |
| CCDC158 | TBC1D12 | O60347 | 416 |
| CCDC158 | ALMS1 | Q8TCU4 | 411 |
| CCDC158 | FAM47E | Q6ZV65 | 407 |
| CCDC158 | PPP6R3 | Q5H9R7 | 403 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPSM1 | CCDC158 | psi-mi:“MI:0915”(physical association) | 0.550 |
| CCDC158 | HSPD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC158 | SLC3A2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC158 | SCGB2A1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC158 | ANKFY1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC158 | USP20 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC158 | USP33 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FCHSD2 | CCDC158 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SH3GLB2 | CCDC158 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SGF29 | CCDC158 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NAGK | CCDC158 | psi-mi:“MI:0915”(physical association) | 0.370 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| CBX2 | TRANK1 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX4 | psi-mi:“MI:0914”(association) | 0.350 | |
| CCDC158 | FOS | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): CCDC158 (Two-hybrid), MYCBP2 (Affinity Capture-MS), SCGB2A1 (Affinity Capture-MS), CCDC158 (Two-hybrid), CCDC158 (Two-hybrid), CCDC158 (Two-hybrid), CCDC158 (Two-hybrid), CCDC158 (Two-hybrid), SCGB2A1 (Affinity Capture-MS), GPSM1 (Two-hybrid), CCDC158 (Two-hybrid), CCDC158 (Two-hybrid), CCDC158 (Two-hybrid), TBC1D21 (Two-hybrid), UBQLN2 (Two-hybrid)
ESM2 similar proteins: A0A8M2BID5, A0A8M9PQ61, A1Z8P9, A6QR54, B4KE73, E9Q7G0, F1R4Y7, O15083, O55156, O60437, O61308, Q11102, Q13439, Q15643, Q3SWS9, Q5DTN8, Q5M9N0, Q5PQ23, Q5RI56, Q5U4E6, Q5VZ66, Q5ZKK5, Q66H89, Q6DFL0, Q6PH08, Q6ZU80, Q7ZW57, Q811U3, Q8BI22, Q8BVL9, Q8CDI6, Q8CDI7, Q8CGB3, Q8HYY4, Q8IUD2, Q8K3M6, Q8WXW3, Q91VW5, Q96AA8, Q96N16
Diamond homologs: Q5M9N0, Q8CDI6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
190 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 171 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3977 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:76333983:T:A | donor_gain | 1.0000 |
| 4:76334009:CA:C | donor_gain | 1.0000 |
| 4:76334021:CAAGG:C | donor_gain | 1.0000 |
| 4:76334042:T:TA | donor_gain | 1.0000 |
| 4:76334049:T:TA | donor_gain | 1.0000 |
| 4:76350991:CT:C | donor_loss | 1.0000 |
| 4:76350994:A:AC | donor_gain | 1.0000 |
| 4:76350994:AC:A | donor_loss | 1.0000 |
| 4:76350995:C:CC | donor_gain | 1.0000 |
| 4:76350995:CA:C | donor_gain | 1.0000 |
| 4:76350995:CAT:C | donor_gain | 1.0000 |
| 4:76350995:CATG:C | donor_gain | 1.0000 |
| 4:76351117:AGTTC:A | acceptor_gain | 1.0000 |
| 4:76351118:GTTC:G | acceptor_gain | 1.0000 |
| 4:76351119:TTC:T | acceptor_gain | 1.0000 |
| 4:76351120:TC:T | acceptor_gain | 1.0000 |
| 4:76351120:TCC:T | acceptor_loss | 1.0000 |
| 4:76351121:CC:C | acceptor_gain | 1.0000 |
| 4:76351122:C:CA | acceptor_loss | 1.0000 |
| 4:76351122:C:CC | acceptor_gain | 1.0000 |
| 4:76351718:A:AC | donor_gain | 1.0000 |
| 4:76351719:C:CC | donor_gain | 1.0000 |
| 4:76353118:ATTAC:A | donor_loss | 1.0000 |
| 4:76353120:TA:T | donor_loss | 1.0000 |
| 4:76353139:T:TA | donor_gain | 1.0000 |
| 4:76353277:TTCTC:T | acceptor_gain | 1.0000 |
| 4:76353279:CTC:C | acceptor_gain | 1.0000 |
| 4:76353281:CCTA:C | acceptor_loss | 1.0000 |
| 4:76353282:C:CC | acceptor_gain | 1.0000 |
| 4:76353283:T:C | acceptor_loss | 1.0000 |
AlphaMissense
7382 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:76355373:A:G | L746P | 1.000 |
| 4:76355390:T:A | R740S | 1.000 |
| 4:76355390:T:G | R740S | 1.000 |
| 4:76355393:T:A | K739N | 1.000 |
| 4:76355393:T:G | K739N | 1.000 |
| 4:76355398:C:G | A738P | 1.000 |
| 4:76313231:A:C | I1094S | 0.999 |
| 4:76313231:A:G | I1094T | 0.999 |
| 4:76323340:A:G | L1076S | 0.999 |
| 4:76323349:A:G | L1073P | 0.999 |
| 4:76355377:C:G | A745P | 0.999 |
| 4:76355403:A:C | I736S | 0.999 |
| 4:76355403:A:G | I736T | 0.999 |
| 4:76355411:T:A | Q733H | 0.999 |
| 4:76355411:T:G | Q733H | 0.999 |
| 4:76355415:A:C | M732R | 0.999 |
| 4:76355415:A:G | M732T | 0.999 |
| 4:76355424:G:T | A729E | 0.999 |
| 4:76355425:C:G | A729P | 0.999 |
| 4:76313231:A:T | I1094N | 0.998 |
| 4:76323331:A:G | L1079P | 0.998 |
| 4:76351742:A:G | L839P | 0.998 |
| 4:76355370:T:G | Q747P | 0.998 |
| 4:76355382:A:T | I743K | 0.998 |
| 4:76355391:C:A | R740I | 0.998 |
| 4:76355391:C:G | R740T | 0.998 |
| 4:76355394:T:A | K739I | 0.998 |
| 4:76355395:T:C | K739E | 0.998 |
| 4:76355403:A:T | I736N | 0.998 |
| 4:76355412:T:G | Q733P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000003967 (4:76420591 G>A), RS1000021944 (4:76354551 G>A), RS1000024359 (4:76423121 C>A), RS1000039166 (4:76408477 G>A), RS10000618 (4:76390715 A>G,T), RS10000821 (4:76387217 G>A,C), RS1000117049 (4:76415406 G>C), RS10001182 (4:76400104 C>T), RS10001396 (4:76329354 C>A,G,T), RS10002302 (4:76395987 T>C), RS10002448 (4:76348109 G>A,C), RS1000252751 (4:76380403 T>G), RS10002558 (4:76390318 T>C,G), RS1000260270 (4:76338937 A>G), RS1000272263 (4:76377879 A>G)
Disease associations
OMIM: gene MIM:621144 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| renal tubule disorder | Limited | Autosomal recessive |
Mondo (1): renal tubule disorder (MONDO:0021568)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000649_16 | Chronic kidney disease | 1.000000e-19 |
| GCST004412_8 | Craniofacial microsomia | 8.000000e-08 |
| GCST007876_84 | Estimated glomerular filtration rate | 2.000000e-72 |
| GCST009391_511 | Metabolite levels | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010527 | pyridoxate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Estradiol | affects binding, increases reaction | 1 |
| Ivermectin | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Methotrexate | decreases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT02256579 | Not specified | UNKNOWN | Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients |
| NCT03253614 | Not specified | COMPLETED | Auditive and Renal Long Term Outcomes - Risk After Aminoglycoside Therapy in Neonates (AURORA) |
Related Atlas pages
- Associated diseases: renal tubule disorder
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): craniofacial microsomia, renal tubule disorder